Sichuan Kelun Pharmaceutical Co Ltd (002422) — Cash Flow Reinvestment Rate
Sichuan Kelun Pharmaceutical Co Ltd (002422) has a Cash Flow Reinvestment Rate of 0.73x as of September 2025, reinvesting CN¥393.58 Million (capex CN¥393.58 Million ) from operating cash flow of CN¥537.31 Million. Check 002422 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sichuan Kelun Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Sichuan Kelun Pharmaceutical Co Ltd across 19 annual periods. Explore Sichuan Kelun Pharmaceutical Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)
Year-by-year capital reinvestment analysis for Sichuan Kelun Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 002422 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.73x | CN¥1.94 Billion | CN¥2.64 Billion | CN¥1.62 Billion | ▲ +84.5% |
| 2024 | 0.40x | CN¥1.78 Billion | CN¥4.49 Billion | CN¥1.68 Billion | ▼ -58.8% |
| 2023 | 0.96x | CN¥5.14 Billion | CN¥5.34 Billion | CN¥1.77 Billion | ▲ +71.8% |
| 2022 | 0.56x | CN¥1.75 Billion | CN¥3.13 Billion | CN¥896.02 Million | ▲ +1.7% |
| 2021 | 0.55x | CN¥1.57 Billion | CN¥2.85 Billion | CN¥990.56 Million | ▼ -24.1% |
| 2020 | 0.73x | CN¥1.61 Billion | CN¥2.22 Billion | CN¥1.23 Billion | ▼ -2.4% |
| 2019 | 0.74x | CN¥1.65 Billion | CN¥2.22 Billion | CN¥1.33 Billion | ▲ +34.5% |
| 2018 | 0.55x | CN¥1.63 Billion | CN¥2.95 Billion | CN¥1.33 Billion | ▼ -71.7% |
| 2017 | 1.95x | CN¥2.35 Billion | CN¥1.20 Billion | CN¥1.48 Billion | ▲ +86.4% |
| 2016 | 1.05x | CN¥1.81 Billion | CN¥1.73 Billion | CN¥1.37 Billion | ▼ -40.4% |
| 2015 | 1.76x | CN¥2.18 Billion | CN¥1.24 Billion | CN¥1.84 Billion | ▼ -22.3% |
| 2014 | 2.26x | CN¥2.76 Billion | CN¥1.22 Billion | CN¥2.76 Billion | ▲ +5.2% |
| 2013 | 2.15x | CN¥2.26 Billion | CN¥1.05 Billion | CN¥2.26 Billion | ▼ -68.8% |
| 2012 | 6.89x | CN¥2.77 Billion | CN¥402.77 Million | CN¥2.77 Billion | ▲ +17.8% |
| 2011 | 5.85x | CN¥2.00 Billion | CN¥342.93 Million | CN¥2.00 Billion | ▲ +34.8% |
| 2010 | 4.34x | CN¥647.22 Million | CN¥149.29 Million | CN¥647.22 Million | ▲ +294.8% |
| 2009 | 1.10x | CN¥275.29 Million | CN¥250.69 Million | CN¥275.29 Million | ▲ +7.1% |
| 2008 | 1.02x | CN¥226.58 Million | CN¥221.08 Million | CN¥226.58 Million | ▼ -1.4% |
| 2007 | 1.04x | CN¥175.05 Million | CN¥168.42 Million | CN¥175.05 Million | — |